
==== Front
Sci Rep
Sci Rep
Scientific Reports
2045-2322
Nature Publishing Group UK London

67709
10.1038/s41598-024-67709-z
Article
Physicochemical characterization and potential cancer therapy applications of hydrogel beads loaded with doxorubicin and GaOOH nanoparticles
Żmuda Aleksandra 1
Kamińska Weronika 1
Bartel Marta 1
Głowacka Karolina 1
Chotkowski Maciej 1
Medyńska Katarzyna 12
Wiktorska Katarzyna 2
Mazur Maciej mmazur@chem.uw.edu.pl

1
1 https://ror.org/039bjqg32 grid.12847.38 0000 0004 1937 1290 Department of Chemistry, University of Warsaw, Pasteura 1, 02-093 Warsaw, Poland
2 https://ror.org/05srvzs48 grid.13276.31 0000 0001 1955 7966 Department of Physics and Biophysics, Institute of Biology, Warsaw University of Life Sciences-SGGW, Nowoursynowska 166, 02-787 Warsaw, Poland
6 9 2024
6 9 2024
2024
14 2082215 2 2024
15 7 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
A new type of hybrid polymer particles capable of carrying the cytostatic drug doxorubicin and labeled with a gallium compound was prepared. These microparticles consist of a core and a hydrogel shell, which serves as the structural matrix. The shell can be employed to immobilize gallium oxide hydroxide (GaOOH) nanoparticles and the drug, resulting in hybrid beads with sizes of approximately 3.81 ± 0.09 μm. The microparticles exhibit the ability to incorporate a remarkably large amount of doxorubicin, approximately 0.96 mg per 1 mg of the polymeric carrier. Additionally, GaOOH nanoparticles can be deposited within the hydrogel layer at an amount of 0.64 mg per 1 mg of the carrier. These nanoparticles, resembling rice grains with an average size of 593 nm by 155 nm, are located on the surface of the polymer carrier. In vitro studies on breast and colon cancer cell lines revealed a pronounced cytotoxic effect of the hybrid polymer particles loaded with doxorubicin, indicating their potential for cancer therapies. Furthermore, investigations on doping the hybrid particles with the Ga-68 radioisotope demonstrated their potential application in positron emission tomography (PET) imaging. The proposed structures present a promising theranostic platform, where particles could be employed in anticancer therapies while monitoring their accumulation in the body using PET.

Keywords

Hydrogel polymer particles
Doxorubicin
GaOOH nanoparticles
Cancer therapy
Ga-68 radioisotope
Positron emission tomography (PET)
Radiolabeled nanoparticles
MDA-MB-231 cell line
HT-29 cell line
Subject terms

Colloids
Gels and hydrogels
Biomedical materials
Drug delivery
Polymers
Drug delivery
Nanocomposites
Polymer characterization
Nuclear chemistry
issue-copyright-statement© Springer Nature Limited 2024
==== Body
pmcIntroduction

Development of novel drug delivery systems has revolutionized the way pharmaceuticals are administered, enhancing their therapeutic efficacy1–3. Among various strategies that have been reported so far, polymer particles are especially promising4. The application of such particles offers useful ways for the incorporation and release of a range of pharmaceuticals. The particles can be designed to encapsulate, protect, and release drugs in a controlled manner5–7. Additionally, their capacity to entrap multiple drugs or contrast agents enables the development of innovative treatment modalities for a range of diseases, from autoimmunological diseases to cancer8–11.

Polymer particles can be modified through chemical post-functionalization of their surface by forming ionic, coordination, or covalent bonds with guest molecules4. If the particles possess charged functional groups on their surface, guest molecules with opposite charges could be attached through ionic interactions12. Alternatively, the post-functionalization of particle surfaces is possible through the formation of coordination bonds13–15. Attaching molecules to particle surfaces is also possible with covalent bonds16,17.

A slightly different strategy for the post-functionalization of polymer particles is to perform the reaction within the polymer material inside the particle, either throughout its entire volume or to a certain depth18. In the latter case, an example are gel-shell particles, which are obtained by reacting the polymer material through attaching appropriate functional groups to polymer chains. For instance, polystyrene particles can be subjected to a sulfonation reaction to form a hydrophilic hydrogel layer by substituting sulfonic groups into aromatic rings19. Such a hydrogel layer with anionic groups can be used to accumulate cationic species. For example, anionic gel-shell particles were used to accumulate silver cations, which were subsequently reduced by addition of a reducing agent to yield silver nanoparticles. This resulted in the fabrication of hybrid beads where metallic nanoparticles were incorporated within the polymer material20–22.

In the current work, hydrogel-shell particles were prepared and used to accumulate the cationic drug doxorubicin as well as a (radio)gallium compound. Doxorubicin, a widely used anticancer drug, contains an amino group that is protonated within an appropriate pH range, allowing it to accumulate in the hydrogel layer through coulombic interaction with anionic groups. Similarly, gallium cations were accumulated in the hydrogel layer and then precipitated at an increased pH, followed by thermal transformation into insoluble gallium oxide hydroxide (GaOOH) in the form of rice grain-shaped nanoparticles (with the potential use of the Ga-68 radioisotope). The co-incorporation of doxorubicin and gallium enables the preparation of a hybrid theranostic platform, containing a therapeutic agent (doxorubicin) and a diagnostic agent (when using the Ga-68 radioisotope).

Doxorubicin is commonly used in the treatment of breast, colon, stomach, and other types of cancer23. Due to its strong cardiotoxicity, doxorubicin is encapsulated in various types of drug carriers to reduce its side effects and enable targeted delivery to the pathological site in the body. Doxorubicin has been encapsulated in a range of polymer carriers such as PLGA24–26, polycaprolactone27, and polylactide28. On the other hand, gallium-68 is widely used in medical diagnostics. This radioisotope undergoes β+ decay with the half-life of 67.7 min, making it suitable for PET imaging29. Stephens et al., utilized microspheres composed of cross-linked sulfonated polystyrene to incorporate gallium (Ga-67) for imaging both normal and VX2 implanted livers of rabbits using SPECT (Single Photon Emission Computed Tomography). However, the potential application of the Ga-68 isotope for similar imaging using PET (Positron Emission Tomography) was also highlighted30. Zyuzin et al.31 used calcium carbonate particles covered with chemically modified human serum albumin capable of incorporating 68Ga3+ ions, to demonstrate their biodistribution after intravenous administration in rats using PET and CT (Computed Tomography). Samantha et al.32 prepared heparin-gold nanoparticles with incorporated Ga-68, which are able to cross the blood–brain barrier to target glioblastoma in a mouse xenograft model.

There are several examples of incorporating a drug and a diagnostic marker into a single type of structure. Ilyas et al.33 reported on the preparation of polydopamine-sealed mesoporous silica nanocarriers capable of carrying doxorubicin, 68Ga and 177Lu as a promising platform for both molecular imaging and therapy of breast cancer. Exosome-based particles modified with an azide group were used as carriers of doxorubicin (and 5-aminolevulinic acid). They were injected into tumor-bearing mice, followed by the injection of a Ga-68 complex containing the dibenzocyclooctyne group, which enabled PET/CT imaging due to click chemistry reaction taking place in vivo34. The use of doxorubicin carriers co-incorporated with other radiometals has also been reported in the literature35.

The integration of the drug and the radioisotope into a single carrier may thus enable its use as a theranostic system. In the current paper, we demonstrate an original method for incorporating gallium ions, including a radioisotope, by integrating gallium oxide hydroxide in the form of rice grain-shaped nanoparticles into the hydrogel carrier. Additionally, we show that the gallium-modified particles can absorb a remarkably large amount of the drug, with an approximate 1:1 weight ratio of doxorubicin to polymeric carrier. These structures are intended as potential drug vehicles for doxorubicin in cancer treatment. Furthermore, the incorporation of the gallium radioisotope may enable tracking of the particles after administration to the body, which could be utilized in image-guided cancer therapy33,36–38.

Results and discussion

The general idea behind the study is preparation of hydrogel particles capable to incorporate drug molecules (doxorubicin) and be detectable with 3D imaging medical diagnostic tools, e.g. positron emission tomography (PET). The preparative procedure consists of three stages. In the first one, the precursor polystyrene particles undergo a sulfonation reaction, which results in their transformation into hydrogel particles. Next, the hydrogel particles are modified with rice-shaped gallium-containing nanoparticles, optionally doped with Ga-68 radioisotope, through the precipitation of Ga3+ cations with OH− ions, followed by thermal transformation into GaOOH. Finally, the modified hydrogel structures are utilized to incorporate doxorubicin drug molecules based on coulombic cation–anion interaction. The scheme of preparative procedure is shown in Fig. 1.Figure 1 Scheme of preparative procedure.

Preparation of hydrogel particles

The first preparative stage was sulfonation of polystyrene particles to yield gel-shell beads. Shown in Fig. 2a and b are scanning electron microscopy (SEM) images of polystyrene (PS) and sulfonated polystyrene (PSS) particles, respectively. While the PS particles appear sharp in the image (their diameter is 3.0 μm), the contours of the PSS beads are diffused. This is not surprising, since it may be assumed the hydrogel shell become collapsed after dryging the sample. We used further transmitted light optical microscopy to image the sulfonated particles (Fig. 2c). First, one can see that the diameter of the particles (4.8 μm) is higher than that of original PS beads. Moreover, one can see much smaller cores (ca. 1.7 μm) within the hydrogel particles. This can be interpreted in such a way, that the sulfonation reaction does not proceed completely, leaving unreacted polystyrene cores.Figure 2 Imaging of polymer particles: (a) SEM of polystyrene particles (PS), (b) SEM of sulfonated polystyrene particles (PSS), (c) optical microscopy in the transmitted white light mode of PSS particles, (d) SEM of PSS particles with incorporated doxorubicin.

This conclusion is further supported by FTIR data acquired for PS and PSS microparticles, respectively (Supplementary Fig. S1)20,39. Characteristic bands for the sulfonic group appear in the PSS spectrum at 1179, 1039 and 1008 cm−1. The first value can be assigned to the asymmetric stretching of SO2 of the sulfonic group, the next two vibrations are due to symmetric stretching. The band at 3443 cm−1 corresponds to the –OH stretching vibration, absent in the case of polystyrene. The band at 3058 cm−1 corresponds to the stretching vibration of the C–H bond at aromatic carbon, while the bands at 2920 and 2844 cm−1 indicate the presence of asymmetric and symmetric vibrations of the aliphatic CH2 group. Two bands at wavenumbers 758 and 699 cm−1 are characteristic of compounds with a single-substituted aromatic ring, as in the case of polystyrene. However, they are much less intense than in the case of PS, which indicates that the PSS microparticles have not been completely sulfonated which is in accordance with microscopic data. Sulfonation of polystyrene particles is also confirmed by EDS (Energy-dispersive X-ray spectroscopy) analysis (Supplementary Fig. S2).

Incorporation of doxorubicin in gel-shell beads

Next, we examined incorporation of doxorubin, a well known cytostatic drug applicable to treat various cancers. Doxorubicin molecule contains an amino group which, when protonated, carries positive charge. The pKa of doxorubicin is 8.4, thus, the molecule is protonated at neutral pH40,41. Since PSS particles contain anionic sulfonic groups, it can be expected that, as a result of electrostatic interactions, the protonated doxorubicin groups (–NH3+) will be attracted to the negatively charged –SO2O- groups. Consequently, doxorubicin molecules should accumulate within the PSS hydrogel layer.

Doxorubicin solution was added to the hydrogel particles which resulted in its rapid decoloration (the doxorubicin solution is intensively red). After separation of the particles through centrifugation they have been examined with SEM (Fig. 2d). One can see that the diameter (4.78 ± 0.09 μm) is considerably higher than that of precursor PS beads (and similar to the diameter of PSS beads). Moreover, the contours of the particles are sharp, unlike PSS. It looks like they have swelled due to the absorption of the doxorubicin molecules.

Next we studied the doxorubicin-containing beads with optical (fluorescence) microscopy (the drug reveals fluorescent properties42–44). Shown in Fig. 3a is fluorescence microscopy image. One can see bright red light projecting from the particles which confirms incorporation of doxorubicin. The corresponding emission spectrum (Fig. 3b) exhibits an emission band with a maximum at 642 nm, which fairly matches the position of solid doxorubicin hydrochloride7. The incorporation of doxorubicin was also confirmed with infrared spectroscopy. Shown in Fig. 3c are FTIR spectra of the particles with incorporated drug (for reference, the spectrum of doxorubicin and PSS beads was included). Comparison of the spectra shows that the spectrum for PSS microparticles with doxorubicin (PSS/Dox) contains signals assigned to both pure doxorubicin and PSS. They are marked with the symbol (*) in colors corresponding to the colors of spectra of individual components. The bands attributable to doxorubicin are found at the following wavenumber values: 1722, 1614, 1579, 1527, 1406, 1280, 1204, 1121, 1078, 966 and 873 cm−1. They are comparable to those for doxorubicin reported in the literature45. On the other hand the PSS bands are found at 1496, 1167 and 1033 cm−1. The signals at the 1442 and 1004 cm−1 wavenumbers are due to both doxorubicin and PSS. The presence of bands from both species in the spectrum confirms the incorporation of doxorubicin in the PSS beads.Figure 3 (a) Fluorescence microscopy image of hydrogel particles with incorporated doxorubicin (PSS/Dox), (b) emission spectrum of an individual PSS/Dox particle (excitation 532 nm), (c) FTIR spectra of doxorubicin and PSS and PSS/Dox particles (signals in the PSS/Dox spectrum originating from pure doxorubicin as well as from PSS are marked with the symbol (*) in colors corresponding to the colors of the spectra of the components).

In order to determine the amount of incorporated doxorubicin within the gel-shell particles we have recorded the change in the absorbance of the solution after incubations with the beads. A simple calculation, taking into account the known mass of PSS particles, yields the value of 0.96 mg of doxorubicin per 1 mg of PSS, which means that considerably large quantity of the drug, comparable to the mass of PSS, was incorporated.

At the same time, the extent to which the incorporated doxorubicin was released into the solution was examined. For this purpose, PSS/Dox particles were incubated in deionized water, and the absorbance of the contacting solution was measured at specific time intervals. Supplementary Fig. S3 shows the curve, indicating that doxorubicin is released gradually at a consistent rate. After 10 h, less than 1.5% of the doxorubicin contained in the particles was released. This result demonstrates that the release of doxorubicin is relatively slow, likely due to the strong interaction between doxorubicin and the sulfonic groups in PSS. The remarkably high sorption capacity of PSS, together with the retarded release of the drug, is promising from the perspective of application in controlled drug delivery.

Incorporation of GaOOH in gel-shell beads

In a set of parallel experiments we examined the possibility to incorporate gallium-containing compounds within the hydrogel beads. It was expected that Ga3+ cations due to positive charge would be accumulated within the hydrogel shells of the particles (as the sulfonic groups are negatively charged). The cations then would be transformed into non-soluble compounds through reaction with anions, e.g. hydroxyl anions.

Gallium(III) oxide hydroxide is known to be formed through dehydration of Ga(OH)3 at elevated temperature46. Therefore, the idea was to precipitate gallium ions with OH− and then transform it to GaOOH. However, we have noticed that the Ga(OH)3 did not precipitate effectively at stoichiometric Ga3+/OH− ratio, which is likely due to the presence of numerous equilibria in the solution47. In order to determine the ratio at which both reagents should be mixed to obtain the largest amount of Ga(OH)3, nephelometric titration of Ga3+ with NaOH or NH3 solutions was performed.

Shown in Fig. 4a are titration curves of Ga3+ solution. One can see that the highest intensity of scattered light is observed at 1.77:1 for NaOH/Ga3+ and 1.20:1 for NH3/Ga3+ molar ratios. Increasing the amount of the base in both cases results in decrease of the intenstity which can be interpreted as gradual dissolution of the precipitate. These ratios have been selected as optimal in further experiments. Nevertheless, as Ga(OH)3 is prone to dissolution, it should be transformed to GaOOH. To check this possibility, the gallium hydroxide precipitate was heated, and then, after separating the precipitate, subjected to X-ray diffraction measurement. Shown in Fig. 4b is diffraction pattern of the obtained product. All observed diffraction peaks correspond to gallium hydroxide oxide, confirming full transformation of Ga(OH)348,49 (the structural parameters50–52 calculated from the the XRD data are included in Supplementary Information; Tables S1 and S2). The morphology of the fabricated GaOOH was also examined using scanning electron microscopy. When NaOH was used in the synthesis, GaOOH crystals were mostly cuboidal, regular shape, with average size of 320 nm × 144 nm (Supplementary Fig. S4). On the other hand, the particles prepared through precipitation with NH3 were longer and thinner than their NaOH counterparts (ca. 375 nm × 103 nm), resembling rice grains (Fig. 4c).Figure 4 (a) Nephelometric titration curves of gallium nitrate solution with ammonia solution (blue line) and sodium hydroxide solution (red line), (b) diffraction pattern of rice grain-like GaOOH nanoparticles (prepared from NH3 solution), (c) SEM image of rice grain-like GaOOH nanoparticles (prepared from NH3 solution), (d) SEM image of PSS/GaOOH particles (prepared from NH3 solution).

The next aim was to incorporate GaOOH nanoparticles into hydrogel beads. The PSS structures were conditioned with a Ga3+ ion solution, followed by the addition of a base solution and heating. It was expected that Ga3+ ions would accumulate in the hydrogel shell as a result of coulombic interactions with sulfonic groups. The addition of OH- ions would result the precipitation of Ga(OH)3, followed by transformation into GaOOH due to increased temperature. In the case of the synthesis using NaOH, some deposit was indeed obtained on the surface of the PSS particles (Supplementary Fig. S5). Unfortunately, it was not regular. Some PSS particles were completely covered with gallium nanorods, while some were practically uncoated. On the other hand, the use of NH3 solution results in preparation of beads regularly coated with GaOOH particles (Fig. 4d).

It can be observed that the particles of the gallium compound have the shape of rice grains, even though they are slightly longer and thicker compared to those prepared in the absence of PSS (593 nm × 155 nm). It seems that the nanoparticles are attached to the surface of the PSS particles, but they do not penetrate deeply. The diameter of the PSS/GaOOH particles is 3.35 ± 0.17 μm, thus, it is slightly higher than the size of the starting PS particles. Some GaOOH particles non-attached to PSS are also visible (it seems they were detached from the PSS matrix during preparative procedures, or they are the result of insufficient separation). Additional detailed analysis with EDS, further confirming the above conclusions, is included in the Supplementary Information (section: EDS analysis of PSS/GaOOH beads, Figs. S6-S9).

In order to determine the efficiency of the incorporation of GaOOH particles in PSS, the Ga-68 isotope was used to label the structures in order to perform radiometric measurements. For this purpose, a solution of stable gallium ions was prepared with the addition of Ga-68 radioisotope with an activity of approximately 10 MBq. The synthesis was then carried out according to the experimental procedure described above, and the supernatants were collected to determine their activity. On this basis, the yield of the preparative process was calculated. Figure 5a shows a histogram illustrating the efficiency of GaOH incorporation at individual preparatory stages. The data show that during subsequent centrifugations, GaOOH rice-shaped nanoparticles unbound to hydrogel beads are removed to some extent, but the final efficiency is relatively high, reaching ca. 77%.Figure 5 (a) Histogram showing the 68GaOOH content in a sample of hydrogel particles during subsequent preparative stages, (b) thermogravimetric curves of PSS (i) and PSS/GaOOH (ii) particles; (c) SEM image of PSS/GaOOH/Dox particles, (d) gamma-ray spectrum of PSS/68GaOOH/Dox particles.

In order to determine the content of GaOOH in the composite we employed thermogravimetric analysis (TGA). Shown in Fig. 5b is thermogram of PSS/GaOOH particles (for reference, the thermogravimetric curve of PSS beads is also shown). One can see, that the decomposition of the PSS/GaOOH beads starts above 100 °C. The mass gradually decrease in several decomposition steps reaching the final value of 43%. On the other hand, the decomposition of PSS yields a residue of 12%. It can therefore be assumed that heating PSS/GaOOH results in the decomposition of PSS, but with the formation of an indecomposable residue. At the same time, GaOOH decomposes into gallium oxide Ga2O3 with the release of water molecules.53 Based on a simple calculation taking into account the above data, it can be estimated that GaOOH content in the composite is ca. 0.64 mg per 1 mg of PSS.

Fabrication of Dox/GaOOH gel-shell beads

We aimed further to obtain PSS particles modified with both doxorubicin and GaOOH (PSS/Dox/GaOOH). For this purpose, first the PSS particles were modified with a gallium compound and then with doxorubicin. The obtained hydrogel structures were examined using scanning electron microscopy. Figure 5c and Fig. S10 (Supplementary Information) show SEM images at different magnifications of hydrogel particles modified with GaOOH and doxorubicin. The diameter of the particles is 3.81 ± 0.09 μm which is somewhat higher than PSS beads with GaOOH (see Fig. 4d), but lower than PSS beads with incorporated doxorubicin (Fig. 2d). This indirectly indicates the incorporation of doxorubicin (fully unambiguous confirmation of the presence of doxorubicin is provided by fluorescence microscopy; the corresponding microscopic images of PSS/GaOOH/Dox particles, in both white light and fluorescence mode, are shown in Supplementary Information, Fig. S11).

On the other hand, radiometric measurements (analogous to those presented in the previous chapter) show that the addition of doxorubicin causes a decrease in the amount of GaOOH by only 4%. This indicates that the incorporation of doxorubicin molecules occurs in a gentle manner and does not substantially result in the removal of GaOOH nanoparticles.

In addition to determining incorporation efficiency, the use of the gallium-68 isotope may have additional applications. Ga-68 is used in PET tomography, so the particles modified with the isotope could be monitored using this technique after administration into the body, which is especially important if they carry a drug (here: doxorubicin). Shown in Fig. 5d is gamma-ray spectrum of the PSS/68GaOOH/Dox sample. The spectrum shows a signal at 511 keV attributed to gamma rays resulting from the annihilation of positrons emitted by Ga-68 contained in the hybrid particles. The Ga-68 activity used here is to demonstrate feasibility of the concept. However, it should be noted, that for PET imaging, significantly higher radioisotope activities would be required.

Cytotoxicity of PSS/GaOOH/Dox particles

In vitro cytotoxicity studies of PSS/GaOOH/Dox beads were performed on the MDA-MB-213 breast cancer cell line. These cells represent a subtype of triple-negative breast cancer that lacks progesterone and estrogen receptors, which makes them insensitive to treatment with antiestrogens, commonly used in breast cancer therapy. The reference cell line was MCF-10A—non-tumorigenic epithelial cells derived from the MCF-10A mammary gland.

Two tests were used to assess antitumor activity: MTT and CVS. The MTT assay is one of the most popular tests assessing the activity of a potential anticancer drug and is an indirect test. It is based on the ability of living cells to reduce a tetrazolium salt to formazan. The obtained formazan has a purple color, the intensity of which is proportional to the amount of the product formed and indirectly proportional to the number of living cells. The second assay used was the direct CVS test, independent of cellular metabolism. The CVS test assesses the amount of dye absorbed by the cell, which depends on the DNA content in the culture and allows for estimating the number of living cells.

Figure 6a, b shows the results of viability studies of MDA-MB-231 breast cancer cells after 72-h incubation in the presence of the hybrid particles.Figure 6 MTT and CVS assays evaluating the effect of PSS/GaOOH/Dox particles on cancer and non-tumorigenic epithelial cell line cultures: (a) MDA-MB-231 cancer cells, (b) MCF-10A non-tumorigenic epithelial breast cells (right panel), (c) HT-29 colon cancer cells, (d) CRL-1790 non-tumorigenic epithelial colon cells.

The histograms for MDA-MB-21 cancer cells and non-tumorigenic epithelial MCF-10A cells incubated in the presence of PSS/GaOOH/Dox beads show that as the concentration of particles increases, cell viability decreases. When comparing histograms for cancer and non-tumorigenic epithelial cells at high concentrations, a slightly higher viability of non-tumorigenic MCF-10A cells that serves as a model of normal cells compared to cancer cells was noted. For the highest concentration of 15 ppm, the viability of cancer cells drops to approximately 15%, and for the model normal cells to approximately 18%.

Analogous in vitro cytotoxicity studies were also performed in the HT-29 colorectal cancer cell line, which in in vitro cultures shows a morphology typical of epithelial cells. The reference cell line was CRL-1790, isolated from normal human colon tissue, representing a model of normal colon cells. Figure 6c, d shows histograms for the HT-29 and CRL-1790 cell lines after 72 h of incubation in the presence of particles. For HT-29 cancer cells, it was observed that with increasing particle concentration, cell viability decreased. The cytotoxic effect of the examined structures on colon cancer HT-29 cells was the strongest in the concentration range of 1.67–15 ppm, where cell viability in this range did not exceed 15% (CVS test) and approximately 23% (MTT test). It should be noted that the highest concentration of 15 ppm turned out to be 3 times less toxic for CRL-1790 cells (MTT test) and 4 times less toxic for CRL-1790 cells (CVS test) than for HT-29 cancer cells. The results clearly indicate reduced toxicity towards non-cancerous cells.

To quantitatively investigate the cytotoxic effect of the particles, the IC50 values were determined (the concentration at which the number of cells in the culture decreases to 50% compared to the control). Since the data for the particles are expressed in ppm (which complicates comparison with the data for doxorubicin in solution), they were recalculated to an effective molar concentration, taking into account the previously determined doxorubicin content in the particles (vide supra). The IC50 values are presented in Table 1 (the IC50 values reported in the literature for doxorubicin not encapsulated in the carrier are also included). Table 1 IC50 values determined using MTT and CVS assays for MDA-MB-231, MCF-10A, HT-29, and CRL-1790 cell lines after 72 h of incubation with PSS/GaOOH/Dox.

	PSS/GaOOH/Dox (in suspension)	doxorubicin in solution	
MTT	CVS	MTT	
[ppm]	[µM]	[ppm]	[µM]	[µM]	
MDA-MB-231	0.40	0.66	0.13	0.22	0.12554	
MCF-10A	0.09	0.15	0.05	0.08	0.02554	
HT-29	0.65	1.08	0.23	0.38	0.75055	
CRL-1790	1.60	2.65	0.65	1.08	x	
IC50 values for doxorubicin (not encapsulated in the carrier) are also presented for selected cell lines.

The IC50 values determined for cells incubated with PSS/GaOOH/Dox particles in the MTT assay for breast cancer cells (MDA-MB-231) was 0.40 ppm (0.66 μM), which was almost 4.5 times higher than that for non-tumorigenic MCF-10A cells. In the CVS test, the IC50 value was 0.13 ppm (0.22 μM) for cancer MDA-MB-231 cells, which was 3 times higher than for MCF-10A cells. These values are rather undesirable because they indicate that the cytotoxicity of doxorubicin is higher for MCF-10A cells than for MDA-MB-231 cells. However, similar behavior of doxorubicin towards MDA-MB-231 and MCF-10A cells is reported in the literature (IC50 values of 0.125 µM and 0.025 µM, respectively)54.

For HT29 colon cancer cells, the IC50 value for the MTT assay is 0.65 ppm (1.08 μM), and for CVS, it is 0.23 ppm (0.38 μM), which is approximately 40% of the IC50 value for colon CRL-1790 cells (the IC50 values of doxorubicin in solution for HT-29 cells is 0.750 μM (MTT)55; we have found no literature data for CRL-1790 cells). This is a much better result than in the case of breast cells, where cancer cells turned out to be less sensitive to the action of cytostatics (whether encapsulated in a carrier or free) compared to non-cancerous cells.

Qualitative microscopic observation of cell cultures was also performed. Staining cells with propidium iodide (PI) and fluorescein diacetate (FDA) allows to visualize live and dead cells and to assess the processes caused by the action of the examined polymer particles in the cells. Figure 7 shows microscopic images of stained MDA-MB-231 and MCF-10A cells after a 72-h incubation in the presence of the PSS/GaOOH/Dox structures.Figure 7 Confocal microscopy images of stained MDA-MB-231 cells (A, B) and MCF-10A cells (C, D) after 72 h of incubation in the presence of PSS/GaOOH/Dox particles at concentrations of 15, 1.67, 0.18, and 0.02 ppm; transmitted light (A, D) and fluorescence modes (B, C).

For concentrations of 1.67 ppm and 15 ppm, no live or dead cells were recorded for both MDA-MB-231 and normal MCF10A breast cell lines. The obtained result may indicate very high cytotoxicity of the tested structures towards cells in this concentration range. In microscopic images of non-cancerous MCF10A cells incubated with 0.18 ppm, dead cells (red) were observed, which were not visible for MDA-MB-231 cancer cells, which may indicate a different mechanism (cytotoxic in MCF-10A and cytostasis or growth arrest in MDA-MB-231 cells) of action of the beads on individual cell lines56.

Microscopic examination was also performed on HT-29 (A, B) and CRL-1790 cell cultures. (Fig. 8). For high concentrations of the studied particles (15 ppm, 1.67 ppm), no live HT-29 cancer cells were observed (only hydrogel particles in the form of red spots were recorded). A different scenario was observed for colon CRL-1790 cells, where, in addition to PSS/GaOOH/Dox particles, numerous living cells were also seen. The findings align with the results from cytotoxicity assessment using MTT and CVS, demonstrating a more pronounced cytotoxic effect on colon cancer HT-29 cells as compared to CRL-1790 normal cells. This is a very important and promising result from the point of view of the potential therapeutic effectiveness of the particles.Figure 8 Confocal microscopy images of stained HT-29 cells (A, B) and CRL-1790 cells (C, D) after 72 h of incubation in the presence of PSS/GaOOH/Dox particles at concentrations of 15, 1.67, 0.18, and 0.02 ppm; transmitted light (A, D) and fluorescence modes (B, C).

The presented results indicate that the PSS/GaOOH/Dox particles exhibit selective cytotoxicity. Increasing the selectivity of the cytotoxic effect by encapsulating doxorubicin is now a priority due to its serious side effects (cardiotoxicity), which prevent safe and effective treatment.57 In addition, the results indicate that efficient incorporation of gallium allows for imaging and tracking the formulation using PET. Such theranostic approach is considered as a beneficial option for the therapy of cancer. Pan et al.58 shown that doxorubicin may be incorporated in drug delivery vehicles together with iron oxide nanoparticles that enable MRI imaging. Similar approach presented Hasannia et al.59. It was shown that doxorubicin may be effectively delivered to the tumor when incorporated in peptosomes hybridized with gold nanorod that allow CT imaging.

Conclusions

Hybrid structures comprising hydrogel particles modified with rice-shaped GaOOH nanoparticles, capable of incorporating cationic drugs such as doxorubicin, were successfully fabricated. These structures hold significant promise for cancer treatment. Additionally, the doping of inorganic nanoparticles within the structures with the Ga-68 isotope presents a potential avenue for diagnostic applications, such as tracking particles post-administration within the body.

The preparation of hybrid particles involves a relatively straightforward multi-stage process. Initially, hydrogel particles containing anionic groups are synthesized, allowing the accumulation of cationic species. This enables the incorporation of GaOOH particles resembling rice grains along with the anticancer drug doxorubicin.

The characterization of the obtained particles was performed with microscopic, spectroscopic, and thermal techniques. In vitro studies conducted on cancer cell cultures showed the cytotoxic potential of the structures containing doxorubicin. At the same time, measurements on model normal cells demonstrated a diminished level of toxicity. These results suggest that the proposed structures are capable of releasing antineoplastic drug and thus exhibit anticancer activity. Moreover, they revealed selectivity in their cytotoxic effect on colon cells, displaying higher cytotoxicity towards cancer cells compared to normal cells. This selective behavior holds promise for the potential therapeutic and diagnostic applications of such structures.

We hope that our work will initiate further research of new theranostic systems. Currently, we are actively working in our laboratory on optimizing the PSS/GaOOH/Dox system to achieve smaller particle sizes and incorporate radioisotopes with higher activity. This optimization will enable in-depth in vitro and in vivo studies, particularly preclinical PET investigations on animals, to confirm the effectiveness of these particles in medical applications.

Experimental

Chemicals

All chemicals were of the highest quality available commercially and were used as received: (polystyrene latex beads 3.0 μm, Sigma Aldrich), doxorubicin hydrochloride (Lancrix), gallium nitrate hydrate (99.999%, Sigma Aldrich), sulfuric acid 98% (reagent grade, POCh), sodium hydroxide (reagent grade, Chempur), ammonia solution 25% (reagent grade, Chempur).

68Ga radionuclide (ε+β+ emitter, τ1/2 = 67.7 min, Eβmax = 1.9 MeV (β+: 88%), Eβmax = 2.9 MeV (ε: 8%)), in the form of [68Ga]GaCl3 in 0.1 M HCl solutions was eluted from the commercially available GalliaPharm®68Ge/68Ga generator (Eckert & Ziegler).

Materials for cell culture, cytotoxicity assays and confocal imaging

2-Propanol (≥ 99,5%, Avantor Performance Materials), ethanol (reagent grade, Avantor Performance Materials), sodium dodecyl sulfate (reagent grade, Sigma-Aldrich), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide MTT (≥ 98%, Sigma Aldrich), crystal violet (Sigma-Aldrich) trypsin/EDTA 0.25% (Sigma Aldrich), growing media: IMDM (Biowest), MEM (Sigma Aldrich), F-12K (Gibco), Fetal Bovine Serum (FBS, Sigma-Aldrich), antibiotic antimycotic solution (100×) (Sigma Aldrich), Non-Essential Amino Acids Solution (Sigma Aldrich), l-Glutamine (Sigma-Aldrich), phosphate buffer (PBS) (Laboratory of General Chemistry, IITD PAS), fluorescein diacetate (Sigma Aldrich) and propidium iodide (≥ 94.0%, Sigma Aldrich).

Aqueous solutions were prepared from high purity water (Milli—Q Plus).

Instrumentation

Scanning electron microscopy data were collected with a Zeiss Merlin field emission SEM. Widefield optical microscope working in white light or fluorescence mode has been used to image the polymer beads. Confocal microscopy images were recorded with Olympus IX70FV500 confocal microscopy.

Fluorescence spectra of doxorubicin incorporated in polymeric particles was acquired with a Labram HR800 spectrometer (Horiba Jobin Yvon) coupled to an Olympus BX41 microscope. (excitation with a 532 nm laser).

Infrared (FTIR) measurements in transmission mode in KBr pellets were acquired with a Nicolet 8700 spectrometer (Thermo Electron Corporation).

Nephelometric data were collecter with LH-TB1000 nephelometer (Sinotester).

XRD patterns were acquired with Bruker D8 Advance diffractometer.

Thermogravimetric analysis was performed with a TGA Q50 apparatus (TA Instruments). The measurements were performed in an oxygen atmosphere.

The Ga-68 activity was determined with an HPGe detector (Canberra, XtRa coaxial detector, efficiency: 40%). The activities of the samples containing this radionuclide were evaluated based on the annihilation peak at 511 keV.

Spectophotometric measurements of cell cultures in multiwell microplates were carried out in Power Wave XS 96-well microplate reader (Bio-Tek).

Preparative and experimental procedures

Preparation of hydrogel particles

To 5 mg of polystyrene particles was added 500 μL of concentrated H2SO4. The sample was heated in a water bath at 55 °C for 19 h. The sample was transferred to an eppendorf and centrifuged followed by removal of residual acid with a pipette. The precipitate was then washed several times through centrifugation with distilled water and then neutralized with 60 mM NaOH in the presence of indicator paper.

Modification of hydrogel beads with rice-shaped GaOOH nanoparticles

In the main experimental protocol, 1 mL of aqueous 20 mM Ga(NO3)3 was added to the hydrogel particles. Then 0.38 mL of 60 mM ammonia solution was added and incubated at 80 °C for 2 h, followed by heating for a further 15 min at 100 °C. After cooling, the sample was transferred to an eppendorf and centrifuged several times and washed with distilled water.

In an alternative procedure, instead of using ammonia solution, 0.56 mL of 60 mM NaOH was used. This procedure yield GaOOH rice-grain-like nanoparticles modifying the PSS beads.

In a separate reference experiment, GaOOH nanoparticles were also obtained without the presence of PSS particles. Such particles were used to carry out XRD measurements. The preparation procedure was analogous to that used for PSS modification (the procedure that uses an ammonia solution to precipitate Ga3+ ions). The only difference was that water was used instead of PSS suspension. After obtaining the nanoparticles, they were purified by centrifugation.

Modification of hydrogel beads with rice-shaped 68GaOOH nanoparticles

For incorporation of radioactive 68GaOOH nanoparticles, the only difference was that the 20 mM Ga(NO3)3 solution additionally contained Ga-68 isotope with activity of ca. 10 MBq.

Incorporation of doxorubicin within hydrogel particles

Distilled water was added to the hydrogel particles (neat or modified with GaOOH) to a volume of 0.5 mL and shaken on a vortex shaker for about 1 min. Then, 0.5 mL of a 3 mM doxorubicin solution was added to the suspension. The sample was shaken, then centrifuged and washed with distilled water until the red color of the solution above the precipitate disappeared.

Cell culture and cytotoxicity assay

The cell lines were purchased from American Type Culture Collection (ATCC).

Cytotoxicity of of the particles was examined against MCF-10A and CRL-1790 normal human cell lines isolated from normal human mammary and colon tissue, respectively, and also in corresponding human cancer cell lines: MDA-MB-231 representing triple negative breast cancer and HT-29 colon cancer cell line. The cells were cultured according to the vendor’s protocol in an apropriate growing medium supplemented with FBS, solution of antibiotics, l-glutamine and non-essential aminoacids solution. The cells were maintained at 37 °C in a humidified incubator with 5% carbon dioxide atmosphere. Upon reaching 80% confluence, cells were trypsinized using 0.25% trypsin and subsequently either subcultured or seeded in a 96-well culture plate for cytotoxic assay, or on Labtek chamber microscopic slides (Nunc, ThermoFisher) for microscopic examination.

Cell viability was examined with both metabolism-dependent MTT (methylthiazoltetrazolium salt) and metabolic-independent CVS (crystal violet staining) cytotoxicity tests. After 72 h of incubation, the medium was removed and each well was washed with 100 μL of PBS. Next, MTT solution (5 mg/mL) or 0.5% CVS solution was added to each well. In the MTT assay, the plates were placed in an incubator (37 °C, 5% CO2) for 3 h, after which 200 μL of isopropyl alcohol was added to each well to dissolve the formazan crystals. In the CVS assay, plates were incubated for 10 min at room temperature, rinsed with deionised water, and 100 μL of a 1% SDS solution was added to each well. The absorbance of the solutions was measured using a plate spectrophotometer at either 570 nm (MTT) or 540 nm (CVS).

For microscopic examination, the cells were stained with a mixture of fluorescein diacetate (FDA, living cells) and propidium iodide (PI, dead cells). 250 µL of the staining solution in PBS: propidium iodide (2.5 µL per 1 mL buffer) and fluorescein diacetate (10 µL per 1 mL buffer), was added to each well for 15 min. Cells were incubated at 37 °C, protected from light. Finally, the cells were analysed using a confocal microscope in sequential mode to avoid fluorescence cross-talk at 488 nm (FDA excitation) and 543 nm (PI excitation).

Supplementary Information

Supplementary Information.

Supplementary Information

The online version contains supplementary material available at 10.1038/s41598-024-67709-z.

Author contributions

A.Ż., M.B., and M.M. designed the study and analyzed the data. A.Ż., W.K., and M.B. performed the synthetic work and conducted the physicochemical characterization of the materials. M.B, K.M., and K.W. collected in vitro data. W.K. and M.C. conducted experimental work with Ga-68 radioisotope. A.Ż., M.B., K.G. and M.M. contributed to the interpretation of the results and the writing of the manuscript.

Data availability

All data generated or analysed during this study are included in this published article (and its Supplementary Information files).

Competing interests

The authors declare no competing interests.

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. McNamara K Tofail SAM Nanoparticles in biomedical applications Adv. Phys.-X 2017 2 54 88 10.1080/23746149.2016.1254570
McNamara, K. & Tofail, S. A. M. Nanoparticles in biomedical applications. Adv. Phys.-X 2, 54–88. 10.1080/23746149.2016.1254570 (2017).10.1080/23746149.2016.1254570
2. Vargason AM Anselmo AC Mitragotri S The evolution of commercial drug delivery technologies Nat. Biomed. Eng. 2021 5 951 967 10.1038/s41551-021-00698-w 33795852
Vargason, A. M., Anselmo, A. C. & Mitragotri, S. The evolution of commercial drug delivery technologies. Nat. Biomed. Eng. 5, 951–967. 10.1038/s41551-021-00698-w (2021).33795852 10.1038/s41551-021-00698-w
3. Pogorzelska A Anticancer effect and safety of doxorubicin and nutraceutical sulforaphane liposomal formulation in triple-negative breast cancer (TNBC) animal model Biomed. Pharmacother. 2023 161 114490 10.1016/j.biopha.2023.114490 36931031
Pogorzelska, A. et al. Anticancer effect and safety of doxorubicin and nutraceutical sulforaphane liposomal formulation in triple-negative breast cancer (TNBC) animal model. Biomed. Pharmacother. 161, 114490. 10.1016/j.biopha.2023.114490 (2023).36931031 10.1016/j.biopha.2023.114490
4. Krug, P. et al. in Materials for Biomedical Engineering (eds. Holban, A. M. & Grumezescu, A. M.) 59–111 (Elsevier, 2019).
5. Daly AC Riley L Segura T Burdick JA Hydrogel microparticles for biomedical applications Nat. Rev. Mater. 2020 5 20 43 10.1038/s41578-019-0148-6 34123409
Daly, A. C., Riley, L., Segura, T. & Burdick, J. A. Hydrogel microparticles for biomedical applications. Nat. Rev. Mater. 5, 20–43. 10.1038/s41578-019-0148-6 (2020).34123409 10.1038/s41578-019-0148-6
6. Karimi M Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems Chem. Soc. Rev. 2016 45 1457 1501 10.1039/c5cs00798d 26776487
Karimi, M. et al. Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems. Chem. Soc. Rev. 45, 1457–1501. 10.1039/c5cs00798d (2016).26776487 10.1039/c5cs00798d
7. Kuśmierz B Wysocki K Chotkowski M Mojzych I Mazur M Preparation of surface-supported polylactide spherical-cap particles Langmuir 2022 38 14596 14606 10.1021/acs.langmuir.2c01950 36395585
Kuśmierz, B., Wysocki, K., Chotkowski, M., Mojzych, I. & Mazur, M. Preparation of surface-supported polylactide spherical-cap particles. Langmuir 38, 14596–14606. 10.1021/acs.langmuir.2c01950 (2022).36395585 10.1021/acs.langmuir.2c01950
8. Srikar R Upendran A Kannan R Polymeric nanoparticles for molecular imaging Wiley Interdiscipl. Rev. Nanomed. Nanobiotechnol. 2014 6 245 267 10.1002/wnan.1259
Srikar, R., Upendran, A. & Kannan, R. Polymeric nanoparticles for molecular imaging. Wiley Interdiscipl. Rev. Nanomed. Nanobiotechnol. 6, 245–267. 10.1002/wnan.1259 (2014).10.1002/wnan.1259
9. Wojtowicz A Nano-radiogold-decorated composite bioparticles Mater. Sci. Eng. C-Mater. Biol. Appl. 2019 97 768 775 10.1016/j.msec.2018.12.085 30678966
Wojtowicz, A. et al. Nano-radiogold-decorated composite bioparticles. Mater. Sci. Eng. C-Mater. Biol. Appl. 97, 768–775. 10.1016/j.msec.2018.12.085 (2019).30678966 10.1016/j.msec.2018.12.085
10. Kijewska K Gold-decorated polymer vessel structures as carriers of mRNA cap analogs Polymer 2015 57 77 87 10.1016/j.polymer.2014.12.019
Kijewska, K. et al. Gold-decorated polymer vessel structures as carriers of mRNA cap analogs. Polymer 57, 77–87. 10.1016/j.polymer.2014.12.019 (2015).10.1016/j.polymer.2014.12.019
11. Kijewska K Magnetic-nanoparticle-decorated polypyrrole microvessels: Toward encapsulation of mRNA cap analogues Biomacromolecules 2013 14 1867 1876 10.1021/bm400250g 23597098
Kijewska, K. et al. Magnetic-nanoparticle-decorated polypyrrole microvessels: Toward encapsulation of mRNA cap analogues. Biomacromolecules 14, 1867–1876. 10.1021/bm400250g (2013).23597098 10.1021/bm400250g
12. Zhang RJ Shell modulation by tailoring substituents in chitosan for LbL-assembled microcapsules J. Colloid Interface Sci. 2012 372 40 44 10.1016/j.jcis.2012.01.026 22305577
Zhang, R. J. et al. Shell modulation by tailoring substituents in chitosan for LbL-assembled microcapsules. J. Colloid Interface Sci. 372, 40–44. 10.1016/j.jcis.2012.01.026 (2012).22305577 10.1016/j.jcis.2012.01.026
13. Mazur M Krysinski P Blanchard GJ Use of zirconium-phosphate-carbonate chemistry to immobilize polycyclic aromatic hydrocarbons on boron-doped diamond Langmuir 2005 21 8802 8808 10.1021/la050921t 16142963
Mazur, M., Krysinski, P. & Blanchard, G. J. Use of zirconium-phosphate-carbonate chemistry to immobilize polycyclic aromatic hydrocarbons on boron-doped diamond. Langmuir 21, 8802–8808. 10.1021/la050921t (2005).16142963 10.1021/la050921t
14. Mazur M Immobilization of laccase on gold, silver and indium tin oxide by zirconium-phosphonate-carboxylate (ZPC) coordination chemistry Bioelectrochemistry 2007 71 15 22 10.1016/j.bioelechem.2006.12.006 17320490
Mazur, M. et al. Immobilization of laccase on gold, silver and indium tin oxide by zirconium-phosphonate-carboxylate (ZPC) coordination chemistry. Bioelectrochemistry 71, 15–22. 10.1016/j.bioelechem.2006.12.006 (2007).17320490 10.1016/j.bioelechem.2006.12.006
15. Xiang XY In vitro & in vivo targeting behaviors of biotinylated Pluronic F127/poly(lactic acid) nanoparticles through biotin-avidin interaction Eur. J. Pharmaceut. Sci. 2012 46 537 544 10.1016/j.ejps.2012.04.011
Xiang, X. Y. et al. In vitro & in vivo targeting behaviors of biotinylated Pluronic F127/poly(lactic acid) nanoparticles through biotin-avidin interaction. Eur. J. Pharmaceut. Sci. 46, 537–544. 10.1016/j.ejps.2012.04.011 (2012).10.1016/j.ejps.2012.04.011
16. Vangara KK Liu JL Palakurthi S Hyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancer Anticancer Res. 2013 33 2425 2434 23749891
Vangara, K. K., Liu, J. L. & Palakurthi, S. Hyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancer. Anticancer Res. 33, 2425–2434 (2013).23749891
17. Kang ML Ko JY Kim JE Im GI Intra-articular delivery of kartogenin-conjugated chitosan nano/microparticles for cartilage regeneration Biomaterials 2014 35 9984 9994 10.1016/j.biomaterials.2014.08.042 25241157
Kang, M. L., Ko, J. Y., Kim, J. E. & Im, G. I. Intra-articular delivery of kartogenin-conjugated chitosan nano/microparticles for cartilage regeneration. Biomaterials 35, 9984–9994. 10.1016/j.biomaterials.2014.08.042 (2014).25241157 10.1016/j.biomaterials.2014.08.042
18. Niu ZW Yang ZH Hu ZB Lu YF Han CC Polyaniline-silica composite conductive capsules and hollow spheres Adv. Funct. Mater. 2003 13 949 954 10.1002/adfm.200304460
Niu, Z. W., Yang, Z. H., Hu, Z. B., Lu, Y. F. & Han, C. C. Polyaniline-silica composite conductive capsules and hollow spheres. Adv. Funct. Mater. 13, 949–954. 10.1002/adfm.200304460 (2003).10.1002/adfm.200304460
19. Yang ZZ Niu ZW Lu YF Hu ZB Han CC Templated synthesis of inorganic hollow spheres with a tunable cavity size onto core-shell gel particles Angew. Chem.-Int. Ed. 2003 42 1943 1945 10.1002/anie.200250443
Yang, Z. Z., Niu, Z. W., Lu, Y. F., Hu, Z. B. & Han, C. C. Templated synthesis of inorganic hollow spheres with a tunable cavity size onto core-shell gel particles. Angew. Chem.-Int. Ed. 42, 1943–1945. 10.1002/anie.200250443 (2003).10.1002/anie.200250443
20. Bartel M Markowska K Strawski M Wolska K Mazur M Silver-decorated gel-shell nanobeads: Physicochemical characterization and evaluation of antibacterial properties Beilstein J. Nanotechnol. 2020 11 620 630 10.3762/bjnano.11.49 32363129
Bartel, M., Markowska, K., Strawski, M., Wolska, K. & Mazur, M. Silver-decorated gel-shell nanobeads: Physicochemical characterization and evaluation of antibacterial properties. Beilstein J. Nanotechnol. 11, 620–630. 10.3762/bjnano.11.49 (2020).32363129 10.3762/bjnano.11.49
21. Zhao K Fabrication of silver-decorated sulfonated polystyrene microspheres for surface-enhanced Raman scattering and antibacterial applications Rsc Adv. 2015 5 69543 69554 10.1039/c5ra11643k
Zhao, K. et al. Fabrication of silver-decorated sulfonated polystyrene microspheres for surface-enhanced Raman scattering and antibacterial applications. Rsc Adv. 5, 69543–69554. 10.1039/c5ra11643k (2015).10.1039/c5ra11643k
22. Liao GF Gong Y Yi CF Xu ZS Soluble, antibaterial, and anticorrosion studies of sulfonated polystyrene/polyaniline/silver nanocomposites prepared with the sulfonated polystyrene template Chin. J. Chem. 2017 35 1157 1164 10.1002/cjoc.201600816
Liao, G. F., Gong, Y., Yi, C. F. & Xu, Z. S. Soluble, antibaterial, and anticorrosion studies of sulfonated polystyrene/polyaniline/silver nanocomposites prepared with the sulfonated polystyrene template. Chin. J. Chem. 35, 1157–1164. 10.1002/cjoc.201600816 (2017).10.1002/cjoc.201600816
23. Tacar O Sriamornsak P Dass CR Doxorubicin: An update on anticancer molecular action, toxicity and novel drug delivery systems J. Pharm. Pharmacol. 2013 65 157 170 10.1111/j.2042-7158.2012.01567.x 23278683
Tacar, O., Sriamornsak, P. & Dass, C. R. Doxorubicin: An update on anticancer molecular action, toxicity and novel drug delivery systems. J. Pharm. Pharmacol. 65, 157–170. 10.1111/j.2042-7158.2012.01567.x (2013).23278683 10.1111/j.2042-7158.2012.01567.x
24. Dinarvand R Sepehri N Manoochehri S Rouhani H Atyabi F Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents Int. J. Nanomed. 2011 6 877 895 10.2147/ijn.S18905
Dinarvand, R., Sepehri, N., Manoochehri, S., Rouhani, H. & Atyabi, F. Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents. Int. J. Nanomed. 6, 877–895. 10.2147/ijn.S18905 (2011).10.2147/ijn.S18905
25. Betancourt T Brown B Brannon-Peppas L Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: Preparation, characterization and in vitro evaluation Nanomedicine 2007 2 219 232 10.2217/17435889.2.2.219 17716122
Betancourt, T., Brown, B. & Brannon-Peppas, L. Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: Preparation, characterization and in vitro evaluation. Nanomedicine 2, 219–232. 10.2217/17435889.2.2.219 (2007).17716122 10.2217/17435889.2.2.219
26. Kalaria DR Sharma G Beniwal V Kumar M Design of biodegradable nanoparticles for oral delivery of doxorubicin: In vivo pharmacokinetics and toxicity studies in rats Pharmaceut. Res. 2009 26 492 501 10.1007/s11095-008-9763-4
Kalaria, D. R., Sharma, G., Beniwal, V. & Kumar, M. Design of biodegradable nanoparticles for oral delivery of doxorubicin: In vivo pharmacokinetics and toxicity studies in rats. Pharmaceut. Res. 26, 492–501. 10.1007/s11095-008-9763-4 (2009).10.1007/s11095-008-9763-4
27. Kukkar D Kaur I Singh J Bharadwaj LM Encapsulation and release of doxorubicin from plasticizer-transformed poly(ε-Caprolactone) microcapsules Polymer-Plast. Technol. Eng. 2018 57 1110 1120 10.1080/03602559.2017.1373395
Kukkar, D., Kaur, I., Singh, J. & Bharadwaj, L. M. Encapsulation and release of doxorubicin from plasticizer-transformed poly(ε-Caprolactone) microcapsules. Polymer-Plast. Technol. Eng. 57, 1110–1120. 10.1080/03602559.2017.1373395 (2018).10.1080/03602559.2017.1373395
28. Brzezinski M Stereocomplexed PLA microspheres: Control over morphology, drug encapsulation and anticancer activity Colloids Surfaces B-Biointerfaces 2019 184 110544 10.1016/j.colsurfb.2019.110544 31655303
Brzezinski, M. et al. Stereocomplexed PLA microspheres: Control over morphology, drug encapsulation and anticancer activity. Colloids Surfaces B-Biointerfaces 184, 110544. 10.1016/j.colsurfb.2019.110544 (2019).31655303 10.1016/j.colsurfb.2019.110544
29. Velikyan I Prospective of 68Ga-radiopharmaceutical development Theranostics 2014 4 47 80 10.7150/thno.7447
Velikyan, I. Prospective of 68Ga-radiopharmaceutical development. Theranostics 4, 47–80. 10.7150/thno.7447 (2014).10.7150/thno.7447
30. Stephens RW In vivo tumour imaging employing regional delivery of novel gallium radiolabelled polymer composites Biomater. Res. 2021 25 1 10.1186/s40824-021-00210-0 33451366
Stephens, R. W. et al. In vivo tumour imaging employing regional delivery of novel gallium radiolabelled polymer composites. Biomater. Res. 25, 1. 10.1186/s40824-021-00210-0 (2021).33451366 10.1186/s40824-021-00210-0
31. Zyuzin MV Radiolabeling strategies of micron- and submicron-sized core-shell carriers for In Vivo studies Acs Appl. Mater. Interfaces 2020 12 31137 31147 10.1021/acsami.0c06996 32551479
Zyuzin, M. V. et al. Radiolabeling strategies of micron- and submicron-sized core-shell carriers for In Vivo studies. Acs Appl. Mater. Interfaces 12, 31137–31147. 10.1021/acsami.0c06996 (2020).32551479 10.1021/acsami.0c06996
32. Samanta S Heparin-derived theranostic nanoprobes overcome the blood-brain barrier and target glioma in murine model Adv. Therapeut. 2022 5 6 10.1002/adtp.202200001
Samanta, S. et al. Heparin-derived theranostic nanoprobes overcome the blood-brain barrier and target glioma in murine model. Adv. Therapeut. 5, 6. 10.1002/adtp.202200001 (2022).10.1002/adtp.202200001
33. Ilyas S Validation of dual-action chemo-radio-labeled nanocarriers with high efficacy against triple-negative breast cancer Acs Appl. Mater. Interfaces 2023 15 48963 48977 10.1021/acsami.3c10579 37831583
Ilyas, S. et al. Validation of dual-action chemo-radio-labeled nanocarriers with high efficacy against triple-negative breast cancer. Acs Appl. Mater. Interfaces 15, 48963–48977. 10.1021/acsami.3c10579 (2023).37831583 10.1021/acsami.3c10579
34. Qian RJ Multi-antitumor therapy and synchronous imaging monitoring based on exosome Eur. J. Nucl. Med. Mol. Imaging 2022 49 2668 2681 10.1007/s00259-022-05696-x 35091755
Qian, R. J. et al. Multi-antitumor therapy and synchronous imaging monitoring based on exosome. Eur. J. Nucl. Med. Mol. Imaging 49, 2668–2681. 10.1007/s00259-022-05696-x (2022).35091755 10.1007/s00259-022-05696-x
35. Shih YH Therapeutic and scintigraphic applications of polymeric micelles: Combination of chemotherapy and radiotherapy in hepatocellular carcinoma Int. J. Nanomed. 2015 10 7443 7454 10.2147/ijn.S91008
Shih, Y. H. et al. Therapeutic and scintigraphic applications of polymeric micelles: Combination of chemotherapy and radiotherapy in hepatocellular carcinoma. Int. J. Nanomed. 10, 7443–7454. 10.2147/ijn.S91008 (2015).10.2147/ijn.S91008
36. Sivapackiam J 68Ga-Galmydar: A PET imaging tracer for noninvasive detection of Doxorubicin-induced cardiotoxicity PloS one 2019 14 e0215579 10.1371/journal.pone.0215579 31120912
Sivapackiam, J. et al. 68Ga-Galmydar: A PET imaging tracer for noninvasive detection of Doxorubicin-induced cardiotoxicity. PloS one 14, e0215579. 10.1371/journal.pone.0215579 (2019).31120912 10.1371/journal.pone.0215579
37. Cho BB In Vitro PET/MRI diagnosis and targeted chemotherapy for cancer using radiolabeled nanoprobe : A theragnostic approach Bull. Korean Chem. Soc. 2016 37 886 892 10.1002/bkcs.10794
Cho, B. B. et al. In Vitro PET/MRI diagnosis and targeted chemotherapy for cancer using radiolabeled nanoprobe : A theragnostic approach. Bull. Korean Chem. Soc. 37, 886–892. 10.1002/bkcs.10794 (2016).10.1002/bkcs.10794
38. Biagiotti G Multiwalled carbon nanotubes for combination therapy: A biodistribution and efficacy pilot study J. Mater. Chem. B 2019 7 2678 2687 10.1039/c8tb03299h 31073405
Biagiotti, G. et al. Multiwalled carbon nanotubes for combination therapy: A biodistribution and efficacy pilot study. J. Mater. Chem. B 7, 2678–2687. 10.1039/c8tb03299h (2019).31073405 10.1039/c8tb03299h
39. Yang JC Jablonsky MJ Mays JW NMR and FT-IR studies of sulfonated styrene-based homopolymers and copolymers Polymer 2002 43 5125 5132 10.1016/S0032-3861(02)00390-7
Yang, J. C., Jablonsky, M. J. & Mays, J. W. NMR and FT-IR studies of sulfonated styrene-based homopolymers and copolymers. Polymer 43, 5125–5132. 10.1016/S0032-3861(02)00390-7 (2002).10.1016/S0032-3861(02)00390-7
40. Yamada Y Dimerization of doxorubicin causes its precipitation ACS Omega 2020 5 33235 33241 10.1021/acsomega.0c04925 33403285
Yamada, Y. Dimerization of doxorubicin causes its precipitation. ACS Omega 5, 33235–33241. 10.1021/acsomega.0c04925 (2020).33403285 10.1021/acsomega.0c04925
41. Wang YX Xu ZF Interaction mechanism of doxorubicin and SWCNT: Protonation and diameter effects on drug loading and releasing Rsc Adv. 2016 6 314 322 10.1039/c5ra20866a 26925231
Wang, Y. X. & Xu, Z. F. Interaction mechanism of doxorubicin and SWCNT: Protonation and diameter effects on drug loading and releasing. Rsc Adv. 6, 314–322. 10.1039/c5ra20866a (2016).26925231 10.1039/c5ra20866a
42. Karukstis KK Thompson EHZ Whiles JA Rosenfeld RJ Deciphering the fluorescence signature of daunomycin and doxorubicin Biophys. Chem. 1998 73 249 263 10.1016/s0301-4622(98)00150-1 9700924
Karukstis, K. K., Thompson, E. H. Z., Whiles, J. A. & Rosenfeld, R. J. Deciphering the fluorescence signature of daunomycin and doxorubicin. Biophys. Chem. 73, 249–263. 10.1016/s0301-4622(98)00150-1 (1998).9700924 10.1016/s0301-4622(98)00150-1
43. Shah S Fluorescence properties of doxorubicin in PBS buffer and PVA films J. Photochem. Photobiol. B-Biol. 2017 170 65 69 10.1016/j.jphotobiol.2017.03.024
Shah, S. et al. Fluorescence properties of doxorubicin in PBS buffer and PVA films. J. Photochem. Photobiol. B-Biol. 170, 65–69. 10.1016/j.jphotobiol.2017.03.024 (2017).10.1016/j.jphotobiol.2017.03.024
44. Nawara K Adsorption of doxorubicin onto citrate-stabilized magnetic nanoparticles J. Phys. Chem. C 2012 116 5598 5609 10.1021/jp2095278
Nawara, K. et al. Adsorption of doxorubicin onto citrate-stabilized magnetic nanoparticles. J. Phys. Chem. C 116, 5598–5609. 10.1021/jp2095278 (2012).10.1021/jp2095278
45. Khan I Nano-co-delivery of berberine and anticancer drug using PLGA nanoparticles: Exploration of better anticancer activity and in vivo kinetics Pharmaceut. Res. 2019 36 149 10.1007/s11095-019-2677-5
Khan, I. et al. Nano-co-delivery of berberine and anticancer drug using PLGA nanoparticles: Exploration of better anticancer activity and in vivo kinetics. Pharmaceut. Res. 36, 149. 10.1007/s11095-019-2677-5 (2019).10.1007/s11095-019-2677-5
46. Downs AJ Chemistry of Aluminium, Gallium, Indium and Thallium 1993 Springer
Downs, A. J. Chemistry of Aluminium, Gallium, Indium and Thallium (Springer, 1993).
47. Fedorova EA Bakhteev SA Maskaeva LN Yusupov RA Markov VF Simulating equilibrium processes in the Ga(NO3)3–H2O–NaOH system Russ. J. Phys. Chem. A 2016 90 1274 1279 10.1134/S0036024416060078
Fedorova, E. A., Bakhteev, S. A., Maskaeva, L. N., Yusupov, R. A. & Markov, V. F. Simulating equilibrium processes in the Ga(NO3)3–H2O–NaOH system. Russ. J. Phys. Chem. A 90, 1274–1279. 10.1134/S0036024416060078 (2016).10.1134/S0036024416060078
48. Huang E A simple synthesis of Ga2O3 and GaN nanocrystals RSC Adv. 2017 7 47898 47903 10.1039/C7RA10639D
Huang, E. et al. A simple synthesis of Ga2O3 and GaN nanocrystals. RSC Adv. 7, 47898–47903. 10.1039/C7RA10639D (2017).10.1039/C7RA10639D
49. Li S-J Zheng C Lobringn KC Refinement of the crystal structure of gallium oxide hydroxide, GaO(OH) New Crystal Struct. 2003 218 11 12 10.1524/ncrs.2003.218.jg.11
Li, S.-J., Zheng, C. & Lobringn, K. C. Refinement of the crystal structure of gallium oxide hydroxide, GaO(OH). New Crystal Struct. 218, 11–12. 10.1524/ncrs.2003.218.jg.11 (2003).10.1524/ncrs.2003.218.jg.11
50. Karthik K Pushpa S Madhukara-Naik M Vinuth M Influence of Sn and Mn on structural, optical and magnetic properties of spray pyrolysed CdS thin films Mater. Res. Innov. 2020 24 82 86 10.1080/14328917.2019.1597436
Karthik, K., Pushpa, S., Madhukara-Naik, M. & Vinuth, M. Influence of Sn and Mn on structural, optical and magnetic properties of spray pyrolysed CdS thin films. Mater. Res. Innov. 24, 82–86. 10.1080/14328917.2019.1597436 (2020).10.1080/14328917.2019.1597436
51. Murugesan R Sivakumar S Karthik K Anandan P Haris M Structural, optical and magnetic behaviors of Fe/Mn-doped and co-doped CdS thin films prepared by spray pyrolysis method Appl. Phys. A 2019 125 281 10.1007/s00339-019-2577-x
Murugesan, R., Sivakumar, S., Karthik, K., Anandan, P. & Haris, M. Structural, optical and magnetic behaviors of Fe/Mn-doped and co-doped CdS thin films prepared by spray pyrolysis method. Appl. Phys. A 125, 281. 10.1007/s00339-019-2577-x (2019).10.1007/s00339-019-2577-x
52. Pradeeswari K Study on the electrochemical performance of ZnO nanoparticles synthesized via non-aqueous sol-gel route for supercapacitor applications Mater. Res. Express 2019 6 105525 10.1088/2053-1591/ab3cae
Pradeeswari, K. et al. Study on the electrochemical performance of ZnO nanoparticles synthesized via non-aqueous sol-gel route for supercapacitor applications. Mater. Res. Express 6, 105525. 10.1088/2053-1591/ab3cae (2019).10.1088/2053-1591/ab3cae
53. Lopes-da-Silva F Laitinen T Pirilä M Keiski RL Ojala S Photocatalytic degradation of perfluorooctanoic acid (PFOA) from wastewaters by TiO2, In2O3 and Ga2O3 catalysts Top. Catalysis 2017 60 1345 1358 10.1007/s11244-017-0819-8
Lopes-da-Silva, F., Laitinen, T., Pirilä, M., Keiski, R. L. & Ojala, S. Photocatalytic degradation of perfluorooctanoic acid (PFOA) from wastewaters by TiO2, In2O3 and Ga2O3 catalysts. Top. Catalysis 60, 1345–1358. 10.1007/s11244-017-0819-8 (2017).10.1007/s11244-017-0819-8
54. Supasena W Enhanced selective cytotoxicity of doxorubicin to breast cancer cells by methoxypolyethylene glycol conjugation via a novel beta-thiopropanamide linker Eur. Polym. J. 2020 141 110056 10.1016/j.eurpolymj.2020.110056
Supasena, W. et al. Enhanced selective cytotoxicity of doxorubicin to breast cancer cells by methoxypolyethylene glycol conjugation via a novel beta-thiopropanamide linker. Eur. Polym. J. 141, 110056. 10.1016/j.eurpolymj.2020.110056 (2020).10.1016/j.eurpolymj.2020.110056
55. Atashpour S Quercetin induces cell cycle arrest and apoptosis in CD133+ cancer stem cells of human colorectal HT29 cancer cell line and enhances anticancer effects of doxorubicin Iran. J. Basic Med. Sci. 2015 18 635 643 26351552
Atashpour, S. et al. Quercetin induces cell cycle arrest and apoptosis in CD133+ cancer stem cells of human colorectal HT29 cancer cell line and enhances anticancer effects of doxorubicin. Iran. J. Basic Med. Sci. 18, 635–643 (2015).26351552
56. Riss, T., Niles, A., Moravec, R., Karassina, N. & Vidugiriene, J. In Assay Guidance Manual (eds. Markossian, S. et al.) (Eli Lilly & Company and the National Center for Advancing Translational Sciences, 2004).
57. Ibrahim M Abuwatfa WH Awad NS Sabouni R Husseini GA Encapsulation, release, and cytotoxicity of doxorubicin loaded in liposomes, micelles, and metal-organic frameworks: A review Pharmaceutics 2022 14 254 10.3390/pharmaceutics14020254 35213987
Ibrahim, M., Abuwatfa, W. H., Awad, N. S., Sabouni, R. & Husseini, G. A. Encapsulation, release, and cytotoxicity of doxorubicin loaded in liposomes, micelles, and metal-organic frameworks: A review. Pharmaceutics 14, 254. 10.3390/pharmaceutics14020254 (2022).35213987 10.3390/pharmaceutics14020254
58. Pan CQ Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment Int. J. Nanomed. 2018 13 1119 1137 10.2147/ijn.S147464
Pan, C. Q. et al. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment. Int. J. Nanomed. 13, 1119–1137. 10.2147/ijn.S147464 (2018).10.2147/ijn.S147464
59. Hasannia M Synthesis of doxorubicin-loaded peptosomes hybridized with gold nanorod for targeted drug delivery and CT imaging of metastatic breast cancer J. Nanobiotechnol. 2022 20 1 10.1186/s12951-022-01607-2
Hasannia, M. et al. Synthesis of doxorubicin-loaded peptosomes hybridized with gold nanorod for targeted drug delivery and CT imaging of metastatic breast cancer. J. Nanobiotechnol. 20, 1. 10.1186/s12951-022-01607-2 (2022).10.1186/s12951-022-01607-2
